Clinical Trials
4 trialsNCT04119024 2026-03-17
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Phase 1 Recruiting
NCT04720417 2025-07-15
Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma
Thomas Jefferson University
Phase 2 Terminated
NCT02654821 2018-11-02
TCR
The Netherlands Cancer Institute
Phase 1/2 Unknown
NCT00705640 2016-12-16
Mel48
University of Virginia
Phase 1 Completed